Skip to main content
Tech.euFundingExplorerBeta

Neogene Therapeutics

Exited

Neogene Therapeutics is a biotech company providing cancer patients with T cell therapies targeting mutated proteins called neo-antigens.

Neogene Therapeutics has raised €93M across 1 funding round from 3 investors, most recently a round in Sep 2020. Based in Amsterdam, Netherlands; founded 2018; active in Healthtech. Acquired by AstraZeneca in 2022. Data as of 28 Oct 2026.

Amsterdam, NetherlandsFounded 2018www.neogene.com ↗
Healthtech
← All companies
Total raised
€93M
€93,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2020-09
latest 2020-09

Funding by year

EUR raised per year
Neogene Therapeutics — funding by year — interactive chart.
Data table
Neogene Therapeutics — funding by year
2020€93M

Funding rounds

1 round
DateStageAmountInvestors
2020-09-14Other€93MEcoR1 Capital,Jeito Capital,Syncona PartnersView deal →

Exit

Type
acquisition
Date
Nov 2022
Value
€310M
Acquiror
AstraZeneca (UK)

Investors

3
EcoR1 CapitalJeito CapitalSyncona Partners

Related news

Similar companies

same sector or country

Global coverage: FundingData